Abstract T-cell therapies for solid tumors are restricted by abnormal tumor vasculature, which creates structural and immunological barriers to infiltration. Here we report a programmable mRNA lipid nanoparticle (LNP) platform that orchestrates a division-of-labor immune response in vivo.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Junsong
Contact Junsong, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack